A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults.
Sheldon EA; Schwartz H; Jiang Q; Giardina PC; Perez JL; Human Vaccines & Immunotherapeutics, 2012, vol. 8, issue 7, p 888, ISSN 2164554x. ISBN 2164554x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef